Organization

ADDICTION RESEARCH AND TREATMENT, INC

According to 2025 Medicare claims, ADDICTION RESEARCH AND TREATMENT, INC (NPI: 1184992331) practices opioid treatment program in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is ADDICTION RESEARCH AND TREATMENT, INC (NPI: 1184992331; TIN: 943303140) and primary practice location at 94025-2539.

The organization's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 58 traditional Medicare patients, billed 2,337 HCPCS/CPT codes, and received $547,499 in Medicare payments. The top billing code was G2067 (Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatm). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $333,821 to $547,499. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$274K$547K2020 Medicare payment: $333,821 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $320,997 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $346,901 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $416,513 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $547,499 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020431,858$333,821
2021481,560$320,997
2022581,745$346,901
2023581,838$416,513
2024582,337$547,499

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

No connected Part D records

No connected Part D records

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G2067Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatm581,861$273
G2074Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)2382$231
G2077Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for3840$138
G2078Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure30348$37

Top 5 Part D drugs in 2024

By total drug costs.

No connected Part D drug-level records for 2024.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for ADDICTION RESEARCH AND TREATMENT, INC?

Tedicare shows public-source Medicare data for ADDICTION RESEARCH AND TREATMENT, INC (NPI 1184992331), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does ADDICTION RESEARCH AND TREATMENT, INC have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to ADDICTION RESEARCH AND TREATMENT, INC?

ADDICTION RESEARCH AND TREATMENT, INC is linked to ADDICTION RESEARCH AND TREATMENT, INC (billing NPI 1184992331) in the available physician profile data.

Does ADDICTION RESEARCH AND TREATMENT, INC have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.